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Abstract
Background: Performing a coronary angiography in patients with heart failure of unknown etiology is often justified 
by the diagnostic assessment of ischemic heart disease. However, the clinical benefit of this strategy is not known.
Objective: To evaluate the prevalence of ischemic heart disease by angiographic criteria in patients with heart failure 
and reduced ejection fraction of unknown etiology, as well as its impact on therapy decisions. 
Methods: Consecutive outpatients with heart failure and systolic dysfunction, who had an indication for coronary 
angiography to clarify the etiology of heart disease were assessed from 1 January 2009 to December 31, 2010. 
Patients diagnosed with coronary artery disease, positive serology for Chagas disease, congenital heart disease, valve 
disease or patients undergoing cardiac transplantation were excluded from the analysis. The sample was divided 
into two groups according to the indication for catheterization. Group-1: Symptomatic due to angina or heart failure. 
Group-2: Presence of ≥ 2 risk factors for coronary artery disease
Results: One hundred and seven patients were included in the analysis, with 51 (47.7%) patients in Group 1 and 
56 (52.3%) in Group 2. The prevalence of ischemic heart disease was 9.3% (10 patients), and all belonged to Group 
1 (p = 0.0001). During follow-up, only 4 (3.7%) were referred for CABG; 3 (2.8%) patients had procedure-related 
complications. 
Conclusion: In our study, coronary angiography in patients with heart failure and systolic dysfunction of unknown 
etiology, although supported by current guidelines, did not show benefits when performed only due to the presence 
of risk factors for coronary artery disease.  (Arq Bras Cardiol 2012;98(5):437-441)
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Noninvasive methods to assess myocardial ischemia in this 
population are of limited use, as the presence of perfusion 
deficits and alterations in segmental mobility are often 
present in patients with non-ischemic heart disease6,7. Thus, 
the assessment of the coronary anatomy by means of cardiac 
catheterization is considered the procedure of choice for the 
investigation of ischemic heart disease in patients with heart 
failure with reduced ejection fraction of unknown etiology8. 
According to current guidelines of chronic heart failure, 
one must consider the performance of cardiac catheterization 
in patients with left ventricular dysfunction of unknown 
etiology in the presence of risk factors for coronary artery 
disease, symptoms of heart failure or refractory angina8. 
However, due to the lack of literature data on the diagnostic 
yield of the invasive strategy in this population, in addition 
to the potential for vascular complications of the procedure, 
its indication becomes unclear.
Objective
To evaluate the prevalence of ischemic heart disease 
using angiographic criteria in patients with heart failure and 
reduced ejection fraction of unknown etiology according 
to different indication criteria, as well as its impact on 
treatment decision-making.
Introduction
Ischemic heart disease accounts for approximately two 
thirds of cases of patients with heart failure with reduced 
ejection fraction in the U.S.¹, being currently the main 
etiology also in Brazil2,3. This etiological differentiation is 
crucial in clinical practice for several reasons. Patients with 
heart failure of ischemic origin have a poorer prognosis 
when compared to other etiologies4. The potential 
benefit of myocardial revascularization procedures 
and pharmacotherapy in the secondary prevention of 
cardiovascular disease is also a key factor that should be 
considered in therapeutic decision-making. 
Patients with heart failure are considered as having 
ischemic etiology when they have a history of myocardial 
infarction, revascularization procedure, or angiographic 
evidence of obstructive coronary artery disease, as shown 
in a previous publication5. 
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Methods
Design
Cross-sectional study followed by a retrospective cohort.
Sample
We analyzed data from patients treated at the outpatient 
clinic for surgical treatment of heart failure in a tertiary 
institution that is a referral for high complexity cases, between 
January 1 2009 and December 31, 2010. We verified all 
elective coronary angiographies performed during this 
period and, subsequently, the sample characteristics were 
retrospectively accessed. The collected variables included: 
echocardiographic data between one year before or after the 
procedure, with calculation of left ventricular ejection fraction 
by Teicholz method, New York Heart Association functional 
class; previous diagnosis of arterial hypertension, diabetes 
mellitus, hypercholesterolemia (patients on statins or LDL – 
cholesterol > 160 mg/dL), family history of early cardiovascular 
disease (men < 45 years and women < 55 years), chronic 
kidney disease (estimated creatinine clearance < 60 mL / min), 
current smoker status or smoker in the past 10 years, presence 
of coronary artery disease (history of myocardial infarction or 
coronary artery bypass grafting or percutaneous intervention). 
We also assessed the serologic results for Chagas disease 
(indirect immunofluorescence method and enzyme linked 
immunosorbent assay), presence of congenital or valvular 
heart disease, and demographic characteristics.
We selected only patients with heart failure and reduced 
ejection fraction that persisted with an unknown etiology after 
initial non-invasive clinical assessment. Inclusion criteria were: 
left ventricular ejection fraction < 45% and age ≥ 18 years. 
Patients with coronary artery disease, positive serology for 
Chagas disease, congenital heart disease, or severe valvular 
disease and those submitted to heart transplantation were 
excluded from the analysis.
The sample was divided into two groups according to 
the criteria for referral to cardiac catheterization. Group 1: 
Symptomatic due to angina or refractory heart failure (i.e., 
NYHA functional class III or IV despite optimal drug therapy), 
regardless of the profile of risk factors for coronary artery 
disease. Group 2: patients without angina and in functional 
class I or II with the presence of ≥ 2 risk factors for coronary 
artery disease (age > 45 years for men and 55 for women, 
hypercholesterolemia, smoking, hypertension, chronic kidney 
disease, family history of premature cardiovascular disease or 
diabetes mellitus).  
After the procedure, patients were classified as patients with 
ischemic or nonischemic etiology. The angiographic criteria 
used were based on previously published definitions by Felker 
et al5, which considered as ischemic etiology patients with 
obstructive lesions (≥ 75%) in two or more epicardial vessels or 
left main coronary artery or the proximal anterior descending 
branch5. Patients defined as having ischemic heart disease 
were evaluated for the indication for surgical or percutaneous 
revascularization during follow-up, according to the attending 
physician’s discretion. The starting date of follow-up was the 
time of coronary angiography and the last date of follow-up 
was considered as the day of revascularization or the last 
outpatient visit recorded in electronic medical records. 
Statistical analysis 
Continuous variables were expressed as means ± standard 
deviation and were compared using the Student’s t test. 
Categorical variables were compared using Fisher exact test. 
Results
A total of 1970 patients were evaluated during the study 
period. After the initial outpatient evaluation and use of 
eligibility criteria, only 107 (5.4%) patients had heart failure 
with left ventricular systolic dysfunction of unknown origin and 
were included in the analysis. Demographic data according 
to the indication for catheterization are shown in Table 1.
Fifty-one patients belonged to Group 1 and 56 to Group 
2. Patients had a mean of 2.5 (± 1.3) risk factors for coronary 
artery disease, with 2.3 (± 1.4) in Group 1 and 2.7 (± 1.2) 
in Group 2 (p = 0.19). 
The prevalence of angiographic alterations consistent with 
ischemic heart disease was 9.3% (10 patients) among the 107 
patients included, all from Group 1 (p = 0.0001). During 
follow-up, only 4 (3.7%) were referred for percutaneous or 
surgical revascularization (Table 2). 
When analyzing patients from Group-1, 19 patients had 
angina and 32 had symptoms of heart failure. The prevalence 
of ischemic heart disease in these subgroups was 26.3% (5 
patients) and 15.6% (5 patients), respectively.
Three patients (2.8%) submitted to catheterization 
had procedure-related complications: one patient had 
acute occlusion of the radial artery, the second had acute 
occlusion of the brachial artery, and the third had ischemic 
cerebrovascular accident.
All patients were alive at the end of the analysis and 
none were lost to follow-up. The mean follow-up was 15.6 
months (± 7.6). 
Discussion
The present study was the first in our country that 
investigated the impact of coronary angiography as a diagnostic 
tool for ischemic heart disease, as well as its influence on 
therapeutic decision for revascularization in patients with heart 
failure and reduced ejection fraction of unknown etiology.
According to the recommendations of current guidelines 
for chronic heart failure, cardiac catheterization should be 
considered in the etiological investigation of patients with 
left ventricular dysfunction in the presence of risk factors for 
coronary artery disease, angina, or refractory symptoms of 
heart failure8.
This study adds value to the literature on this subject as it 
deals with the use of these recommendations in a “real-life” 
sample of patients. 
In the population studied, the coronary angiography 
confirmed the ischemic etiology of heart disease in 9.3% 
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of patients, but only 3.7% had indication for therapeutic 
intervention with coronary revascularization. In a separate analysis 
by subgroups, no patient among those who had an indication 
given only by the presence of risk factors for coronary artery 
disease, showed angiographic criteria consistent with ischemic 
heart disease.  
Previous work with cardiac catheterization in patients with 
heart failure have shown a prevalence of ischemic heart disease 
that varies between 13% and 65%4,5,9. These differing results may 
be explained by the lack of uniformity of the angiographic criteria 
for ischemic heart disease and the difference in the characteristics 
of the studied population. 
The present study included only patients who persisted with 
an unidentified etiology for ventricular dysfunction after the initial 
assessment, excluding those with already established coronary 
artery disease.
The inclusion of mildly symptomatic patients in functional 
class I and slightly reduced ventricular function may also have 
contributed to the low prevalence of ischemic heart disease in 
our population.
In Brazil there are few data on the prevalence and etiology 
of heart failure with reduced ejection fraction. Similar to 
international case series, ischemic heart disease is the main cause, 
accounting for about 32% of cases3.
It is important to mention that the definition used for ischemic 
heart disease in this study was developed from the concept, 
widely accepted and quoted in the literature, that ischemic 
etiology has a worse survival when compared to other forms of 
heart failure with reduced ejection fraction. Thus, patients with 
single-vessel lesions and no history of myocardial infarction or 
revascularization are classified as nonischemic, as they have a 
better prognosis4,5.
Literature data show a low overall rate of complications 
(1.7%) when cardiac catheterization is performed for diagnostic 
purposes in unselected patients from experienced centers10. 
However, patients with dilated cardiomyopathy or with 
symptoms of heart failure are at high risk for complications, 
having the risk increased by 3.3 and 2.2 times, respectively11. 
The rate of procedure-related complications in the study 
sample was 2.8%, whereas only 3.7% of patients benefited 
from a therapeutic intervention based on information obtained 
from the coronary angiography. Thus, the rate of complications 
compared with the potential benefit of the procedure should 
be considered at the moment when the indication for the 
examination is made.  
It is known that some patients with myocardial infarction 
develop partial or complete recanalization of the culprit coronary 
artery that caused the event, resulting in their misclassification as 
an important cause of ischemic cardiomyopathy by the coronary 
angiography. In a study using cardiac magnetic resonance 
imaging in patients with dilated cardiomyopathy and coronary 
angiography without obstructive lesions, 13% showed patterns 
of late enhancement with gadolinium indistinguishable from 
those shown in coronary artery disease12. 
On the other hand, the presence of asymptomatic coronary 
artery disease in patients with dilated cardiomyopathy, with no 
evidence of previous infarction or hibernating myocardium, 
does not demonstrate causality, especially when other etiologies 
for heart failure are present (hypertension, alcoholism, 
myocarditis). The development of severe coronary obstruction 
was demonstrated in a study with 55 patients undergoing 
Table 1 – Basal characteristics of the two groups
Variable Group-1 (n = 51) Group-2 (n = 56) p
Male Sex 38 (74.5%) 39 (69.6%) 0.67
Age (years) 53.1 (±9.8) 52.9 (±12.2) 0.95
Diabetes 13 (25.5%) 16 (28.6%) 0.83
Hypertension 30 (58.8%) 41 (73.2%) 0.15
Smoking 9 (17.6%) 11 (19.6%) 0.81
FH CAD 4 (7.8%) 6 (10.7%) 0.74
Hypercholesterolemia 20 (39.2%) 25 (44.6%) 0.69
CKD 7 (13.7%) 10 (17.9%) 0.61
LVEF 27.6% (±7.7) 28.2% (±7.6) 0.57
FH CAD – family history of early coronary artery disease; CKD –chronic kidney disease; LVEF – left ventricular ejection fraction.
Table 2 – Stratified results according to the indication for coronary angiography
Group-1 
(n = 51)
Group-2 
(n = 56) p
Ischemic cardiopathy 10 0 0.0001
Revascularization 4 0
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cardiac transplantation with a pre-transplant diagnosis of 
idiopathic dilated cardiomyopathy13.  
All patients had angiographically normal coronary arteries 
during a period of up to 10 years before transplantation and had no 
history of myocardial infarction. The examination of the explanted 
heart disclosed critical lesions in at least one coronary segment in 
15 patients (27%) with no evidence of myocardial fibrosis. Similar 
findings were demonstrated in a report of 291 patients with 
biventricular dysfunction and no history of myocardial infarction 
that underwent coronary angiography and endomyocardial biopsy 
due to symptoms of progressive heart failure. Seven (2.4%) had 
significant obstructive lesions, but biopsy in all cases showed 
histological alterations with definitive criteria for myocarditis14. 
Once again, it was not possible to discriminate the predominant 
etiology of ventricular dysfunction in these patients. 
The current advances in computed tomography with multiple 
detectors provided a noninvasive assessment of coronary 
anatomy without loss of specificity of other noninvasive methods. 
A recent study compared the method with cardiac catheterization 
in 93 patients with dilated cardiomyopathy and found a 95% 
accuracy in the diagnosis of ischemic heart disease when 
compared to catheterism15. However, the use of this method is 
relatively recent in this population, requiring further studies to 
establish its actual usefulness. 
Finally, the study has some limitations. This is a retrospective 
analysis, thus subject to biases inherent to this methodology such 
as obtaining data on the indication of coronary angiography 
(selection bias) or the presence of symptoms, which are 
sometimes underreported (measurement bias). Another limitation 
is the fact that it was a single-center study with a sample 
referred to a subspecialty outpatient clinic of a tertiary hospital. 
Furthermore, the number of patients included in the analysis 
was relatively small. 
Conclusion
In our study, the performance of coronary angiography in 
patients with heart failure and reduced ejection fraction of 
unknown etiology, although supported by current guidelines, 
showed no benefits when indicated solely by the presence of 
risk factors for coronary artery disease. In patients with symptoms 
of refractory heart failure or angina, the coronary angiography 
showed to be a good tool for the diagnosis of ischemic heart 
disease. However, even in this population, few were referred 
for myocardial revascularization procedure.
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